Reported Feb 12, 2020 · Terminated

Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort…

Teva Pharmaceuticals USA

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Teva Pharmaceuticals USA · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120

Is this the product you have?

  • Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only
  • Manufactured byActavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA
  • Distributed byActavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01
Lot codes and dates
    • Lot #: 1269726M
    • exp. date 01/2020
    • 1283269M
    • 1283270M
    • exp. date 03/2020
    • 1292992M
    • 1292993A
    • exp. date 04/2020
Amount recalled
69,012 bottles

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

  • Nationwide

Why it was recalled

GMP Deviations: Product bottle may be absent of desiccant.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teva Pharmaceuticals USA recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Dec 10, 2020 · Data as of Sep 19, 5:03 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.